NovaBridge Biosciences (NBP) Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Intangibles for 6 consecutive years, with $16.4 million the latest figure, recorded in Q4 2023.

• In Q4 2023, Intangibles fell 1.87% year-over-year to $16.4 million; the TTM figure through Dec 2023 stood at $16.4 million (down 1.87% YoY), while the FY2023 annual figure was $16.7 million, down 99.9% from the prior year.
• Intangibles was little changed at $16.4 million in Q4 2023 per NBP's latest filing, from $16.3 million in the prior quarter.
• Across five years, Intangibles topped out at $18.7 billion in Q4 2021 and bottomed at $16.3 million in Q2 2023.
• Historically, Intangibles has averaged $1.9 billion across 5 years, with a median of $18.1 million in 2020.
• Annual changes were most pronounced in 2021 — Intangibles soared 102886.2% — and 2022, when it tumbled 99.91%.
• NovaBridge Biosciences' Intangibles stood at $21.1 million in 2019, then decreased by 13.94% to $18.2 million in 2020, then jumped by 102886.2% to $18.7 billion in 2021, then sank by 99.91% to $16.7 million in 2022, then slipped by 1.87% to $16.4 million in 2023.
• Business Quant data shows NBP's Intangibles at $16.4 million in Q4 2023, $16.3 million in Q2 2023, and $16.7 million in Q4 2022.